AIM
CDMO

Aigen Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Aigen Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,757
Closed -$253K – 1141
2023
Q3 		$253K Buy
+26,757
New +$322K 0.05% 582

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Aigen Investment Management's CDMO Position: Q4 2023 in Review

Aigen Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 26,757 shares — an estimated $253K sold.

Aigen Investment Management first reported a position in CDMO in Q3 2023 and held it in 1 quarter. The position peaked at $253K in Q3 2023. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Aigen Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Aigen Investment Management sold 26,757 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $253K.
  • Aigen Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Aigen Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $253K in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Aigen Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.